ADULT;
APOCRINE CARCINOMA;
BREAST BIOPSY;
BREAST CARCINOMA;
CANCER RISK;
CASE REPORT;
CONFERENCE PAPER;
CYTOLOGY;
FEMALE;
HUMAN;
MAMMOGRAPHY;
NEEDLE BIOPSY;
ADULT;
APOCRINE GLANDS;
BIOPSY, NEEDLE;
BREAST NEOPLASMS;
CARCINOMA, INTRADUCTAL, NONINFILTRATING;
CELL NUCLEOLUS;
FEMALE;
FIBROCYSTIC BREAST DISEASE;
HUMANS;
PRECANCEROUS CONDITIONS;
SCLEROSIS;
Apocrine cystic metaplasia: Subgross pathology and prevalence in cancer-associated versus random autopsy breasts
DOI 10.1016/S0046-8177(87)80169-7
Wellings S, Alpers C. Apocrine cystic metaplasia: subgross pathology and prevalence in cancer-associated versus random autopsy breasts. Hum Pathol. 1987:18(4):381-386. (Pubitemid 17071037)
Papillary apocrine change of the breast: Associations with atypical hyperplasia and risk of breast cancer
Page DL, Dupont WD, Jensen RA. Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 1996;5(1):29-32.
Ductal carcinoma in situ of the breast with apocrine cytology: Definition of a borderline category
O'Malley FP, Page DL, Nelson EH, et al. Ductal carcinoma in situ of the breast with apocrine cytology: definition of a borderline category. Hum Pathol. 1994;25(2):164-168.
Atypical apocrine adenosis of the breast: A clinicopathologic study of 37 patients with 8.7-year follow-up
DOI 10.1002/(SICI)1097-0142(19960615)77:12<2529::AID-CNCR16>3.0. CO;2-U
Seidman JD, Ashton M, Lefkowitz M. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow up. Cancer. 1996;77(12):2529-2537. (Pubitemid 26000009)